Molecular mechanisms of radiation-induced accelerated repopulation

Radiation Oncology Investigations

Volumn 7, Issue 6, 1999, Pages 321-330

  Schmidt Ullrich, Rupert K ^a   Contessa, Joseph N ^a   Dent, Paul ^a   Mikkelsen, Ross B ^a   Valerie, Kristoffer ^a   Reardon, Dean B ^a,b   Bowers, Geoffrey ^a,c   Lin, Peck Sun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Cell proliferation; ErbB receptor Tyr kinases; Mitogen activated protein kinase; Radiation; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIACYLGLYCEROL; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL KINETICS; CELL PROLIFERATION; CELL REGENERATION; GROWTH REGULATION; IONIZING RADIATION; ONCOGENE RAS; PARACRINE SIGNALING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; TRANSCRIPTION INITIATION;

EID: 0033398661     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:6<321::AID-ROI2>3.0.CO;2-Q     Document Type: Article

References (48)

1. Denekamp J. Changes in the rate of repopulation during multi-fraction irradiation of mouse skin. Br J Radiol 1973;46:381-392.
2. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
3. Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 1991;22:161-166.
4. Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, Kean T, O'Sullivan B, van Dyk J, Gupta N. et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995;33:549-562.
5. Fowler JF, Lindstrom MH. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-467.
6. Ang KK, Peters LJ. Concomitant boost radiotherapy in the treatment of head and neck cancers. Semin Radiat Oncol 1992;2:31-33.
7. Schmidt-Ullrich RK, Johnson CR, Wazer DE, Masko G, Chasin WD, Karmody CS. Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: Concomitant boost technique. Int J Radiat Oncol Biol Phys 1991;21:563-568.
8. Wang CC. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Radiat Oncol Biol Phys 1988; 14:1143-1146.
9. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997;15:1191-1197.
10. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K. Signal transduction and cellular radiation responses. Radiat Res 1999; in press.
11. Chrysogelos SA, Dickson RB. Epidermal growth factor receptor expression and function in breast cancer. Breast Cancer Res Treat 1994;29:29-40.
12. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 1995;10:1813-1821.
13. Gamett DC, Greene T, Wagreich AR, Kim HH, Koland JG, Cerione RA. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2, p85. J Biol Chem 1995;270: 19022-19027.
14. Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KL III. Insect cell-expressed p180 erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 1994;91:8132-8136.
15. Riese DJ II, Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998;20:41-48.
16. Segatto O, Lonardo F, Wexler D, Fazioli F, Pierce JH, Bottaro DP, White MF, Di Fiore PP. The juxtamembrane regions of the epidermal growth factor receptor and gp185 erbB2 determine the specificity of signal transduction. Mol Cell Biol 1991;11:3191-3202.
17. Zhang K, Sun J, Liu N, Wen D, Chang D, Thomason A, Yoshinaga SK. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem 1996;271:3884-3890.
18. Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 1995;35:115-132.
19. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO 1997;16:1647-1655.
20. Gulliford TJ, Huang GC, Ouyang X, Epstein RJ. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2. Oncogene 1997;15:2219-2223.
21. Qian W, LeVea CM, Freeman JK, Dougall WC, Greene MI. Heterodimerization of EGFR and wild type or kinase deficient Neu: a mechanism of inter-receptor kinase activation and trans-phosphorylation. Proc Natl Acad Sci USA 1994;91:1500-1504.
22. Schmidt-Ullrich RK, Valerie K, Chan W, McWilliams D. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 1994;29:813-819.
23. Schmidt-Ullrich RK, Valerie K, Fogleman B, Walters J. The Radiation-induced autophosphorylation of epidermal growth factor-receptor in human malignant mammary and squamous epithelial cells. Radiat Res 1996; 145:79-83.
24. Redemann N, Holzmann B, Rueden TV, Wagner EF, Schlessinger J, Ullrich A. Anti-oncogenic activity of signaling-defective epidermal growth factor receptor mutants. Mol Cell Biol 1992;12:491-498.
25. Contessa J, Reardon D, Todd D, Dent P, Mikkelsen RB, Valerie K, Schmidt-Ullrich R. Transfection of mutagenesis-deficient EGFR-CD533 disrupts the ionizing radiation-induced activation of EGFR and results in altered signal transduction responses. Clin Cancer Res 1999;5:405-411.
26. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 1994;265:1093-1095.
27. Levitzki A. Targeting signal transduction for disease therapy. Med Oncol 1997;14:83-89.
28. Kavanagh B, Dent P, Schmidt-Ullrich RK, Chen P, Mikkelsen RB. Calcium-dependent stimulation of MAP-kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res 1998;149:579-587.
29. Kasid U, Suy S, Dent P, Ray S, Whiteside TL, Sturgill TW. Activation of Raf by ionizing radiation. Nature 1996;382:813-816.
30. Todd D, Mikkelsen RB, Valerie K, Saady M, Walters J, Schmidt-Ullrich RK. Ionizing radiation stimulates existing signal transduction pathways involving the activation of epidermal growth factor receptor, ErbB-3, and changes of intracellular Ca2+ in A431 human squamous carcinoma cells. J Recept Res Signal Transd 1999;19:885-908.
31. Uckun FM, Schieven GL, Tuel-Ahlgren LM, Dibirdik I, Myers DE, Ledbetter JA, Song CW. Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B- lymphocyte precursors. Proc Natl Acad Sci USA 1993;90:252-256.
32. 2+] in human epithelial cells. Cancer Res 1994;54:5224-5230.
33. Nakajima T, Yukawa O. Mechanism of radiation-induced diacylglycerol production in primary cultured rat hepatocytes. Radiat Res 1999: 40:135-144.
34. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 1998; 95:12202-12207.
35. Reardon D, Dent P, Mikkelsen RB, Valerie K, Contessa J, Schmidt-Ullrich RK. Dominant negative EGFR-CD533 and inhibition of MAPK modulate JNK1 activation and enhance radiation toxicity of human carcinoma cells. Oncogene 1999;18:4756-4766.
36. Davis RJ. Transcriptional regulation by MAP kinases. Mol Reprod Dev 1995;42:459-467.
37. Auer KL, Park JS, Seth P, Coffey RJ, Darlington G, Abo A, McMahon M, Depinho RA, Fisher PB, Dent P. Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF-1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J 1998;336:551-560.
38. Cheng M, Wang D, Roussel MF. Expression of c-Myc in response to colony-stimulating factor-1 requires mitogen-activated protein kinase kinase-1. J Biol Chem 1999;274:6553-6558.
39. Carter S, Auer KL, Birrer M, Fischer PB, Schmidt-Ullrich R, Valerie K, Mikkelsen R, Dent P. Inhibition of the mitogen-activated protein kinase cascade potentiates cell killing by low dose radiation in A431 human squamous carcinoma cells. Oncogene 1998;16:2787-2796.
40. Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K, Schmidt-Ullrich R. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell 1999;10:2493-2506.
41. Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 1998;58:4375-4382.
42. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677.
43. Kavanagh B, Lin P-S, Schmidt-Ullrich R. Repeated low dose radiation exposures in vitro induce accelerated proliferation in human squamous cell carcinoma cell lines as a threshold response. Clin Cancer Res 1995;1: 1557-1562.
44. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96: 857-868.
45. Bottazzi ME, Zhu X, Bohmer RM, Assoian RK. Regulation of p21 (cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol 1999;146:1255-1264.
46. Takuwa N. Fukui Y, Takuwa Y. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol 1999;19:1346-1358.
47. Townsend KJ, Zhou P, Qian L, Bieszczad CK, Lowrey CH, Yen A, Craig RW. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation. J Biol Chem 1999;274:1801-1813.
48. Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol Cell Biol 1999;19: 321-329.